NTT-ELECTRONICS
13.11.2019 07:02:08 CET | Business Wire | Press release
NTT Electronics, a leading provider of advanced components for optical communications systems including coherent optics and digital signal processors (DSPs), contributes the Goldstone Network Operating Software (NOS *1) for disaggregated coherent transponders to the Telecom Infra Project’s NOS Software Project hosted by the Open Optical and Packet Transport project group. Launched in February 2016, TIP was started with the goal of accelerating the pace of innovation in the telecom industry.
Goldstone utilizes many existing open source components which have been developed in Open Compute Project (OCP *2) and Telecom Infra Project (TIP *3) including Open Network Linux (ONL *4), SONiC *5, Switch Abstraction Interface (SAI *6) and Transponder Abstraction Interface (TAI *7) to provide a full-fledged open source solution. ONL is used as the base operating system and provides a wide range of open network device support. On top of ONL, Kubernetes *8 is employed to enable containerized application management, which realizes flexible and modular software composition. SONiC/SAI is deployed as a fleet of containers when the target hardware comprises Ethernet switch ASIC, whereas TAI is used when the target hardware has coherent transponder components. Because of its modular architecture, Goldstone can be extended to support networking devices, which don’t have Ethernet ASIC, but may include conventional transponders, ROADMs or amplifiers in the future.
Goldstone was originally started as a prototype NOS for Edgecore’s Cassini Platform by the proposal from NTT Electronics. This has led to a production deployment by mixi in Japan.
More than five industry partners are using Goldstone for evaluation on the Cassini platform.
It is also being incorporated in Wistron’s Galileo platform.
The NOS is planned to be contributed to TIP Open Optical Packet Transport (OOPT *9) group as an open source project. Goldstone is planned to be part of a live running demonstration at the TIP Summit 2019.
Quote from mixi, Inc.
“As the first operator who deployed Goldstone in production, mixi welcomes the contribution of Goldstone by NTT Electronics to foster more collaboration among the open networking industry. Goldstone brought us huge flexibility and control over our DCI connectivity which is critical for our services” Tatsuma Murase, CTO, mixi, Inc.
Quote from Edgecore
“Edgecore is pleased to be working with NTT Electronics and the broader industry community to enable disaggregated solutions with open packet transponders that will provide broader optical technology choices for network operators.” George Tchaparian, President and CEO, Edgecore Networks
Quote from Wistron
“Wistron is excited to have Goldstone in the open networking industry. Goldstone will accelerate the adaptation of the open disaggregated networking model and we believe it will become a viable solution together with our latest Galileo platform.” Arthur Chang, Sr. Technical Director, Wistron
*1 Network Operating System (NOS) : Operating system for a network device such as a router, switch or firewall.
*2 Open Compute Project (OCP) : The Open Compute Project (OCP) is a collaborative community focused on redesigning hardware technology to efficiently support the growing demands on compute infrastructure. In 2011, Facebook shared its designs with the public and launched the Open Compute Project and incorporated the Open Compute Project Foundation along with Intel, Rackspace, Goldman Sachs and Andy Bechtolsheim. (Reference: OCP web site: https://www.opencompute.org/ )
*3 Telecom Infra Project (TIP) : The Telecom Infra Project (TIP) is a collaborative telecom community founded by Facebook and partners. Launched in February 2016, TIP was started with the goal of accelerating the pace of innovation in the telecom industry. TIP members include operators, suppliers, developers, integrators, startups, and other entities that have joined TIP to build new technologies and develop innovative approaches for deploying telecom network infrastructure. (Reference: TIP web site: https://telecominfraproject.com/ )
*4 Open Network Linux (ONL) : Open Network Linux(ONL) is an open-source, foundational platform software layer for next-generation, modular NOS architecture on open networking hardware. ONL is a part of the Open Compute Project and is a component in a growing number of commercial NOS stacks and open source projects like CoRD & Stratum. (Reference: ONL web site : http://opennetlinux.org/ )
*5 Software for Open Networking in the Cloud (SONiC) : Open source software developed by Microsoft, etc.. It dramatically enhances operations and management of network switches. (Reference: SONiC repository: http://azure.github.io/SONiC/ )
*6 Switch Abstraction Interface (SAI) : The Switch Abstraction Interface (SAI) defines the API to provide a vendor-independent way of controlling forwarding elements, such as a switching ASIC, an NPU or a software switch in a uniform manner. (Reference: SAI repository: https://github.com/opencomputeproject/SAI )
*7 Transponder Abstraction Interface (TAI) : The Transponder Abstraction Interface (TAI) is the open API to provide a vendor-independent way of controlling coherent optical components. TAI has been developed under TIP OOPT group and NTT is leading the development. https://www.ntt.co.jp/news2018/1810e/181016c.html
*8 Kubernetes : Kubernetes is a portable, extensible, open-source platform for managing containerized workloads and services. Google open-sourced the Kubernetes in 2014. (Reference: Kubernetes web site : https://kubernetes.io/ )
*9 Open Optical Packet Transport (OOPT) : The Open Optical & Packet Transport project group will define Dense Wavelength Division Multiplexing (DWDM) open packet transport architecture that triggers new innovation and avoids implementation lock-ins. Open DWDM systems include open line system & control, transponder & network management and packet-switch and router technologies. (Reference: TIP web site: https://telecominfraproject.com/oopt/ )
About NTT Electronics
NTT Electronics (NEL) has been developing and commercializing optical communications devices since 1995. It has complete portfolio of optical and electronics products to cover the industry needs for 100G-and-beyond link systems, ROADM components and FTTH networks. For more information about NEL, visit https://www.ntt-electronics.com/en/ .
View source version on businesswire.com: https://www.businesswire.com/news/home/20191112006191/en/
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
International Human Rights Lawyer Jared Genser and Former White House Counsel Lanny J. Davis Join Legal and Advocacy Team Supporting Cambodian Businessman Yim Leak, Seiden Law LLP Announces18.9.2026 19:52:00 CEST | Press release
Jared Genser, one of the world's most recognized international human rights lawyers, and Lanny J. Davis, an adviser to former presidents George W. Bush and Bill Clinton, join the legal and advocacy team for Cambodian businessman Yim Leak and challenge what they call a coordinated smear campaign in Thailand. International human rights lawyer Jared Genser and Lanny J. Davis, who has close ties to two former US presidents and a worldwide reputation for defending those under attack with lies and smears, and for repairing the damage done to their reputations, have joined the legal and advocacy team supporting Cambodian businessman Yim Leak, Seiden Law LLP, which serves as Yim Leak's chief global counsel, announced today. Their first move is to hold the Thai government accountable, framing its conduct as either complicit in or willfully blind to a sustained smear campaign against Yim. Genser is Managing Director of Perseus Strategies, an international law firm. Over more than two decades, he
Ningbo FEED Meeting Confirms Full Confidence in Q1 2027 FID for Allied Biofuels’ US$6.1 Billion Presidential Decree-Backed SAF and e-SAF Project18.9.2026 17:38:00 CEST | Press release
Allied Biofuels has held a major Front-End Engineering Design (FEED) meeting at Sinopec’s office in Ningbo, China, bringing together Allied Biofuels, Sinopec Engineering Group Co., Ltd. of China, Topsoe A/S of Denmark, Sasol South Africa Limited, and Plug Power of the United States — the principal international engineering and technology providers supporting its US$6.1 billion Presidential Decree-backed Sustainable Aviation Fuel (SAF) and e-SAF project in Uzbekistan. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260918708077/en/ FEED Meeting - Ningbo, China At the joint FEED meeting of the project’s core engineering and technology stakeholders, the discussions established clear alignment on engineering responsibilities, technology interfaces, design deliverables, project integration and the coordinated execution programme required to advance the project through FEED. All stakeholders working on the project expressed full co
Corcept Announces CHMP Opinion Recommending EU Marketing Authorization for Lifyorli® (Relacorilant)18.9.2026 14:00:00 CEST | Press release
Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage company engaged in the discovery and development of medications to treat severe endocrinologic, oncologic, metabolic and neurologic disorders by modulating the effects of the hormone cortisol, today announced that the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has recommended that the European Commission (EC) should approve relacorilant, combined with the chemotherapy drug nab-paclitaxel, for the treatment of patients with platinum-resistant ovarian cancer. The CHMP’s recommendation is based on positive data from Corcept’s Phase 2 and pivotal Phase 3 ROSELLA trials, in which patients receiving relacorilant combined with nab-paclitaxel experienced improved progression-free and overall survival compared to patients who received nab-paclitaxel alone. The safety profile of relacorilant plus nab-paclitaxel in these trials was consistent with the safety profile of nab-paclitaxel monoth
Enhertu® Recommended for Approval in the EU by CHMP as Adjuvant Treatment for Patients with Residual Disease After Neoadjuvant Treatment for HER2 Positive Early Breast Cancer18.9.2026 14:00:00 CEST | Press release
Recommendation based on DESTINY-Breast05 phase 3 trial results that showed Enhertu reduced the risk of invasive disease recurrence or death by 53% versus T-DM1 Daiichi Sankyo and AstraZeneca’s Enhertu has the potential to become a new standard of care in this early breast cancer setting Enhertu® (trastuzumab deruxtecan) has been recommended for approval in the European Union (EU) as a monotherapy for the adjuvant treatment of adult patients with resected HER2 positive breast cancer who have residual invasive disease after neoadjuvant taxane-based and HER2 targeted treatment. Enhertu is a specifically engineered HER2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) based its positive opinion on results from the DESTINY-Breast05 phase 3 trial presented at th
CHMP Recommends EU Approval of New Indication for Alfasigma’s Jyseleca® (filgotinib), Treatment of Adults With Axial Spondyloarthritis18.9.2026 12:58:00 CEST | Press release
The information contained within this press release is for the purpose of scientific exchange.It is intended for scientific, financial and investor media only.If approved, Jyselecawill be indicated for the treatment of patients with active axial spondyloarthritis (axSpA), both non-radiographic and radiographic forms of the disease, who have responded inadequately to conventional therapy.Despite the availability of multiple treatment options, nearly half of people living with axSpA do not respond adequately to current therapies, and just 10-20% reach inactive disease within 16-24 weeks of initiating treatment.CHMP’s positive opinion is based on findings from the OLINGUITO Phase 3 study, where improvements in the signs and symptoms of axSpA with filgotinib were observed early and maintained over 52 weeks of treatment.Jyselecais already approved in Europe and the United Kingdom, for the treatment of moderate to severe rheumatoid arthritis and ulcerative colitis. Alfasigma S.p.A, a global
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
